2023-505085-28-00已完成1 期
A PHASE 1 STUDY TO ASSESS THE MASS BALANCE, PHARMACOKINETICS, AND METABOLISM OF ORAL [14C]-ZIPALERTINIB IN HEALTHY ADULT MALE SUBJECTS
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 8
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Trial Information Desk
Scientific
Taiho Oncology Inc.
研究点 (1)
Loading locations...
相似试验
已完成
1 期
A Phase 1 Study to Assess Mass Balance, Pharmacokinetics, and Metabolism of [14C]Subasumstat in Patients With Advanced or Metastatic Solid Tumors2023-503449-79-00Takeda Development Center Americas Inc.6
已完成
1 期
A phase 1 study to assess the mass balance, pharmacokinetics, metabolism, and excretion of GSBR-1290, containing a microtracer dose of [14C] GSBR-1290, in healthy participants2024-512578-83-00Structure Therapeutics Inc., Structure Therapeutics Inc.8
撤回
不适用
An Investigation of the Mass Balance, Pharmacokinetics, Excretion and Metabolism of [14C]-Nanatinostat in Patients with Advanced Solid Tumors: A Phase 1, Open-Label StudyNL-OMON51840Viracta Therapeutics, Inc.6
已完成
不适用
A Phase 1 Trial to Assess the Mass Balance, Absolute Bioavailability, and Pharmacokinetics of 14C ASTX660 in Healthy Volunteerssolid tumors, lymphomaadvanced solid tumors10024324lymphomaNL-OMON49455Astex Pharmaceuticals, Inc.8
已完成
不适用
A Phase 1 Study to Assess the Mass Balance, Absolute Bioavailability, and Pharmacokinetics of 14C-ASTX029 in Healthy Volunteersadvanced solid tumorssolid tumorsNL-OMON51576Astex Pharmaceuticals, Inc.8